Frederick M. Lowery - 24 Feb 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Frederick M. Lowery
Issuer symbol
TMO
Transactions as of
24 Feb 2025
Net transactions value
-$5,876,679
Form type
4
Filing time
26 Feb 2025, 16:06:32 UTC
Previous filing
21 Feb 2025
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $3,855,444 +18,300 +108% $210.68 35,254 24 Feb 2025 Direct
transaction TMO Common Stock Sale $9,732,123 -18,300 -52% $531.81 16,954 24 Feb 2025 Direct F1
holding TMO Common Stock 1,146 24 Feb 2025 by 401K
holding TMO Common Stock 5 24 Feb 2025 by Limited Liability Company F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -18,300 -100% $0.000000 0 24 Feb 2025 Common Stock 18,300 $210.68 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2024.
F2 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F3 The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.